West-Ward Doxercalciferol Capsules Recall: Illegible Print on Capsules
West-Ward recalls 0.5mcg Doxercalciferol capsules with illegible print. This may cause confusion in medication use. Check your NDC 0054-0338-19 or lot KB60707 from 10/31/2018.
Lower-risk recall
Failed Tablet/Capsule Specifications; during an internal inspection, capsules were found with illegible print.
Contact the company
What happened, in plain English
West-Ward is recalling Doxercalciferol capsules that have illegible printing on the capsule. This could lead to confusion about the medication, especially since these are prescription-only drugs. Read more at govinfonow.com/recall/41771-west-ward-doxercalciferol-capsules-recall-illegible-print-on-capsules.
Source Summary by GovInfoNow · govinfonow.com/recall/41771-west-ward-doxercalciferol-capsules-recall-illegible-print-on-capsules · Updated October 8, 2026 · FDA enforcement record: FDA #D-0651-2017
Cite this page
“West-Ward Doxercalciferol Capsules Recall: Illegible Print on Capsules.” GovInfoNow, updated October 8, 2026. https://govinfonow.com/recall/41771-west-ward-doxercalciferol-capsules-recall-illegible-print-on-capsules. Based on FDA recall #D-0651-2017 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0651-2017%22&limit=1).
Why it’s dangerous
The capsules have illegible printing, which could lead to confusion about the medication. Since these are prescription-only drugs, incorrect identification might cause medication errors.
Who’s affected
Prescription holders of Doxercalciferol capsules 0.5mcg, 50-count bottles with NDC 0054-0338-19 and lot KB60707 from 10/31/2018. People taking this medication for conditions like low calcium levels are most at risk.
How to tell if you have this one
Check for capsules with NDC 0054-0338-19 and lot number KB60707 manufactured on 10/31/2018. These are prescription-only Doxercalciferol capsules 0.5mcg, 50-count bottles.
- Brand
West-Ward- Category
Drug
What to do — step by step
Check Capsule Label
Look for illegible printing on the capsule label to confirm if it is part of the recall.
Where it went and when
Where it was distributed
Distributed in Ohio, and outside the U.S.
FDA distribution: “The recalled product was distributed to the following state: OH. There are no Canada accounts for this recall. There are no Mexico accounts for this recall. There are no government accounts for this recall.” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: Ohio.
Recall timeline
FDA terminated this recall 17 months after the firm started it.
- Firm started the recall
- FDA classified it Class III
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0651-2017 (April 4, 2017) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0651-2017 to see it in context.
- Plain-language summary written by qwen3:4b on October 8, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.